Aciclovir (oculair)

Generic name
Aciclovir (oculair)
Brand name
ATC Code
S01AD03

Aciclovir (oculair)

Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Pharmacokinetics in children

No information is present at this moment.

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

Available formulations

No information is present at this moment.

Dosages

Eye infection, herpes simplex keratitis
  • Ocular
    • Eye salve
      • Term neonate
        [1]
        • Apply 1 cm of salve to the lower conjunctival sac 5 times daily.

        • Duration of treatment:

          Until at least 3 days after complete healing

      • 1 month up to 18 years
        [1]
        • Apply 1 cm of salve to the lower conjunctival sac 5 times daily.

        • Duration of treatment:

          Until at least 3 days after complete healing

Renal impaiment in children > 3 months

No information available on dose adjustment in renal impairment.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects

No information is present at this moment.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions

No information available on specific warnings and precautions in children.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

ANTIINFECTIVES

This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.

Antibiotics
S01AA26
S01AA11
S01AA24
S01AA12
ANTIBIOTICS
S01AA26
S01AA11
S01AA24
S01AA12
Fluoroquinolones
S01AE07
S01AE01

Reference

  1. GlaxoSmithKline, SPC Zovirax oogzalf (RVG 09248) 16-3-2016, www.geneesmiddeleninformatiebank.nl

Changes

Therapeutic Drug Monitoring


Overdose